Advanced Human Imaging Ltd (ahi) Logo

Advanced Human Imaging Ltd (AHI)

___:___ · Technology
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

AHI Chart

Snapshot

AHI's Principal Activity is the ongoing development of its mobile application technology and commercialisation of the MyFiziq app.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -90.35%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,604 of 2,418
Sector Rank 142 of 234

Key Fundamentals

Shares Issued
Sector Technology
Similar Companies SKF / CF1 / CNW
EPS -$0.168
DPS $0.00
Book Value Per Share $0.01

Broker Consensus

AHI is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Date Heading Pages File Size Time

Corporate Overview

Advanced Human Imaging Ltd (AHI, formerly MyFiziq Limited) is a software company which has developed and patented a proprietary measurement/dimensioning technology that enables an end user to check, track, and accurately assess their body dimensions privately using only a smartphone. The Company refers to this physical measurement and analytics tool as “BodyScan." AHI also provides a multi-scan solution comprising of FaceScan, MKScan, HemaScan and DermaScan.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office South Perth WA 6151
Website www.advancedhumanimaging.com
Registry Automic Group
Auditor PKF Perth
Date Listed 17 Aug 2015

Upcoming Calendar (Forecasted)

Date Event
30/08/2022 Report (Prelim)
28/10/2022 Report (Annual)
27/02/2023 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr Simon Francis Durack Chief Financial Officer,Company Secretary Mar 2022
Dr Katherine Iscoe Chief Executive Officer,Executive Director Feb 2022

Dr Katherine Iscoe

Chief Executive Officer,Executive Director

Dr Iscoe has academic and practical experience in medical sciences, health and wellness. Dr Iscoe has co-founded Advanced Human Imaging in 2014 and served as its CEO from April 2015 until October 2016. She has experience in Type 1 Diabetes and glucose optimization through continuous glucose monitoring systems (CGMS). Her work in Type 1 Diabetes spanned several years and includes publications in multiple international peer-reviewed journals. Her biomedical research has provided insight on the differences between interstitial glucose and blood glucose levels, which result in a measurement reading when using CGMS.

Mr Edward F Greissing Jr Non-Executive Director Nov 2021

Mr Edward F Greissing Jr

Non-Executive Director

Mr Greissing Jr is a Senior Fellow with the Milken Institute, and the CEO of Greissing Strategic Advisors. Previously he was the Executive Director for the Centre of Public Health at the Milken Institute. Before his time with the Milken Institute, he served as a member of the Executive Committee, Global Leadership Team, and Senior Vice President of Corporate Affairs at Sanofi. During his nearly four decades in the biopharmaceutical industry, he led a range of Public Affairs and Global Corporate Affairs teams, first at the Upjohn Company and Pharmacia and later with Sanofi. His strategic approach to stakeholder management included new product launches and a freshness program for life cycle management. Previously he served as President and Chief Executive Officer of Red Line Associates, a consulting firm with clients from the biopharmaceutical, device, food service, and financial industries. Before entering the industry in 1978, he was on the U.S. Senate Intelligence Committee staff, served in the United States Army, and was a military policeman assigned to the Honor Detail at Fort Myer at Arlington Cemetery. He also chairs Corporate Governance Committee and is a member of Risk Management Committee as well as Compensation Committee.

Ms Luisa Ingargiola Non-Executive Director Feb 2021

Ms Luisa Ingargiola

Non-Executive Director

Ms Ingargiola has almost 20 years of experience in public company finance, compliance, capital markets oversight and mergers and acquisitions. She currently serves as Chief Financial Officer of a NASDAQ biotech firm and Audit Chair of several Public companies including AgEagle (NYSE: UAVS), Vision Marine (NASDAQ:VMAR) and Progress Acquisition Corporation (NASDAQ:PGRWU), a new SPAC that recently completed their IPO. She has served multiple public companies in various Officer and Director roles. Ms Ingargiola has helped guide the uplist or IPO of several companies to NASDAQ or the NYSE.

Mr Koon Poh Low Non-Executive Director Jul 2020

Mr Koon Poh Low

Non-Executive Director

Mr Low has 23 years of combined experience in accounting, auditing and consultancy, with experience in corporate finance, auditing, and accounting in various industries such as construction, plantation, hotels, property, manufacturing and marketing. Mr Low has served as the director of the Advanced Human Imaging since July 2020. Mr Low started his accounting services practice KL Management Services, based in Petaling Jaya, in 2006. Mr Low has also served the President of IPO Partners Limited, a corporate advisory firm since April 2015, and a director of Round Table Partners Berhad since 2019. Since June 2019, Mr Low has served the Executive Chairman and Chief Executive Officer of Medi Lifestyle Limited, a Healthcare and Wellness company listed in the Singapore Exchange. Prior to his position at KL Management Service, Mr Low worked as an auditor for an international audit firm, an accountant for a Japanese MNC, plus a couple of years as Financial Controller for two public listed companies in Malaysia. Mr Low is currently a director of Singaporean listed company, Medi Lifestyle Limited (appointed 1 June 2019).

Mr Nicholas (Nick) Prosser Non-Executive Director,Interim Chairman Apr 2018

Mr Nicholas (Nick) Prosser

Non-Executive Director,Interim Chairman

Mr Prosser has over a decade of experience in technology expansion and monetization. Mr Prosser has been serving on the Board of Directors of numerous ASX listed companies. He is a founder of Canberra Data Centres, which was acquired by Infratil and Commonwealth Superannuation Corporation in 2016.

Mr Michael (Mike) Melby Non-Executive Director Oct 2017

Mr Michael (Mike) Melby

Non-Executive Director

Mr Melby is co-founder & co-Chief Executive Officer of FitLab, an integrated media & technology holding company focused on fitness & sport lifestyle. He is also co-founder of Mayweather Boxing + Fitness. Previously, Mr Melby was Vice President at New Evolution Ventures, where he invested in and operated health clubs worldwide and served as an executive at UFC Gym. Prior to that, he was co-founder of two technology startups (both of which exited to publicly traded companies), a private equity investor with ClearLight Partners and an investment banker with FBR Capital Markets. Mr Melby has not served as a director of any other listed companies in the 3 years immediately before the end of the 2021 financial year.

Director Transactions

AHI directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
08/02/22 Edward Greissing Jr Issued 700,000 $0.41 $287,000 Issue of options
08/02/22 Nicholas (Nick) Prosser Issued 1,000,000 $0.41 $410,000 Issue of securities
08/02/22 Michael (Mike) Melby Issued 1,000,000 $0.41 $410,000 Issue of securities
23/04/21 Nicholas (Nick) Prosser Issued 1,000,000 $1.79 $1,790,000 Issue of securities
12/03/21 Vlado Bosanac Issued 2,000,000 $1.955 $3,910,000 Conversion of securities
12/03/21 Vlado Bosanac Exercise 2,000,000 $1.955 $3,910,000 Conversion of securities
16/12/20 Nicholas (Nick) Prosser Issued 1,000,000 $1.065 $1,065,000 Issue of securities
16/07/20 Dato Koon Poh Low Sell +444,989 $0.245 ($109,022) Off-market trade
16/07/20 Dato Koon Poh Low Sell +57,379 $0.285 ($16,353) Off-market trade

Director Interests

The current holdings of AHI directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Katherine Iscoe 15/02/2022 N/A 16,900,000 N/A N/A
Edward Greissing Jr 08/02/2022 N/A 0 700,000 N/A
Nicholas (Nick) Prosser 08/02/2022 6,515,036 750,000 N/A N/A
Michael (Mike) Melby 08/02/2022 0 4,000,000 N/A N/A
Koon Poh Low 30/06/2021 300,000 N/A N/A N/A
Luisa Ingargiola N/A N/A N/A N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Oct 19, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Mad Scientist Pty Ltd 16,900,000 12.34%
The Rain Maker Mgmt Sdn Bhd 8,309,840 6.07%
Pheakes Pty Ltd <Senate A/C> 7,001,177 5.11%
Mr Nicholas John Blair Prosser 6,265,036 4.58%
Citicorp Nominees Pty Limited 5,512,816 4.03%
<The Vb Account> 5,391,864 3.94%
Dr. Amar El-Sallam 5,350,000 3.91%
Bnp Paribas Noms Pty Ltd <Drp> 3,753,355 2.74%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 3,654,442 2.67%
Terence Stupple 3,500,000 2.56%
Fitlab Fund Management Llc 3,000,000 2.19%
J15I Pte Ltd (W E F 16/06/2017) 2,466,375 1.80%
HSBC Custody Nominees (Australia) Limited 2,205,224 1.61%
Ifm Pty Limited 2,014,959 1.47%
Mr David Andrew Tabb 1,750,771 1.28%
Dennis And Janine Banks 1,662,898 1.21%
Mr John Zaccaria <The Zaccaria Share A/C> 1,300,000 0.95%
Mr Willy Chan Foo Weng 1,103,380 0.81%
Bnp Paribas Noms Pty Ltd <Uob Kay Hian Priv Ltd Drp> 1,076,263 0.79%
Netwealth Investments Limited <Wrap Services A/C> 965,596 0.71%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 2,014 1,941 555 582 118 5,210

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Pheakes Pty Ltd 19/10/2021 7,001,177 5.11
Mad Scientist Pty Ltd 19/10/2021 16,900,000 12.32
The Bank of New York Mellon Corporation 28/03/2022 21,004,435 12.60

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
22-02-22 The Bank of New York Mellon Corporation 4,367,769 11.98 14.64
10-01-22 The Bank of New York Mellon Corporation 3,045,945 15.13 17.02
06-01-22 The Bank of New York Mellon Corporation 2,272,710 13.47 15.13
23-12-21 The Bank of New York Mellon Corporation 2,303,700 12.33 13.47
16-12-21 The Bank of New York Mellon Corporation 2,137,605 11.00 12.33
14-12-21 The Bank of New York Mellon Corporation 1,938,825 9.80 11.00
09-12-21 The Bank of New York Mellon Corporation 3,008,023 7.93 9.80
23-11-21 The Bank of New York Mellon Corporation 14,000,000 -- 8.96

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
28-03-22 The Bank of New York Mellon Corporation 1,714,811 13.62 12.60
08-03-22 The Bank of New York Mellon Corporation 1,362,424 14.64 13.62
11-02-22 The Bank of New York Mellon Corporation 1,715,826 13.19 11.98
07-02-22 The Bank of New York Mellon Corporation 2,127,825 14.34 13.19
01-02-22 The Bank of New York Mellon Corporation 2,314,382 15.74 14.34
26-01-22 The Bank of New York Mellon Corporation 1,583,120 17.02 15.74
10-12-21 The Rain Maker MGMT SDN BHD 8,279,840 5.21 --
30-11-21 The Bank of New York Mellon Corporation 1,251,754 8.96 7.93
24-11-21 The Rain Maker MGMT SDN BHD 546,815 6.47 5.21
01-06-21 The Rain Maker MGMT SDN BHD 2,128,444 8.13 6.47

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2021 $1.305 30 June
AHI Historical Price Data (CSV)
Up to 20 years of EOD share price history
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.